ISRG Quote, Financials, Valuation and Earnings

Boston Scientific Corp. has a net margin of 27.89% compared to Intuitive Surgical, Inc.'s net margin of 12.68%. Intuitive Surgical, Inc.'s return on equity of 16.59% beat Boston Scientific Corp.'s return on equity of 12.55%.

Intuitive Surgical, Inc. has a consensus price target of $611.82, signalling upside risk potential of 22.48%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.75 which suggests that it could grow by 38.34%. Given that Boston Scientific Corp. has higher upside potential than Intuitive Surgical, Inc., analysts believe Boston Scientific Corp. is more attractive than Intuitive Surgical, Inc..

Intuitive Surgical, Inc. has a beta of 1.653, which suggesting that the stock is 65.303% more volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.441%.

Intuitive Surgical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.

Intuitive Surgical, Inc. quarterly revenues are $2.9B, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. Intuitive Surgical, Inc.'s net income of $799.5M is higher than Boston Scientific Corp.'s net income of $670M. Notably, Intuitive Surgical, Inc.'s price-to-earnings ratio is 63.42x while Boston Scientific Corp.'s PE ratio is 39.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical, Inc. is 18.00x versus 5.64x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Insulet Corp. has a net margin of 27.89% compared to Intuitive Surgical, Inc.'s net margin of 12.96%. Intuitive Surgical, Inc.'s return on equity of 16.59% beat Insulet Corp.'s return on equity of 17.89%.

Intuitive Surgical, Inc. has a consensus price target of $611.82, signalling upside risk potential of 22.48%. On the other hand Insulet Corp. has an analysts' consensus of $357.00 which suggests that it could grow by 43.32%. Given that Insulet Corp. has higher upside potential than Intuitive Surgical, Inc., analysts believe Insulet Corp. is more attractive than Intuitive Surgical, Inc..

Intuitive Surgical, Inc. has a beta of 1.653, which suggesting that the stock is 65.303% more volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.412, suggesting its more volatile than the S&P 500 by 41.175%.

Intuitive Surgical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical, Inc. pays -- of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.

Intuitive Surgical, Inc. quarterly revenues are $2.9B, which are larger than Insulet Corp. quarterly revenues of $783.8M. Intuitive Surgical, Inc.'s net income of $799.5M is higher than Insulet Corp.'s net income of $101.6M. Notably, Intuitive Surgical, Inc.'s price-to-earnings ratio is 63.42x while Insulet Corp.'s PE ratio is 71.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical, Inc. is 18.00x versus 6.58x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Stryker Corp. has a net margin of 27.89% compared to Intuitive Surgical, Inc.'s net margin of 11.84%. Intuitive Surgical, Inc.'s return on equity of 16.59% beat Stryker Corp.'s return on equity of 15.17%.

Intuitive Surgical, Inc. has a consensus price target of $611.82, signalling upside risk potential of 22.48%. On the other hand Stryker Corp. has an analysts' consensus of $424.40 which suggests that it could grow by 13.88%. Given that Intuitive Surgical, Inc. has higher upside potential than Stryker Corp., analysts believe Intuitive Surgical, Inc. is more attractive than Stryker Corp..

Intuitive Surgical, Inc. has a beta of 1.653, which suggesting that the stock is 65.303% more volatile than S&P 500. In comparison Stryker Corp. has a beta of 0.873, suggesting its less volatile than the S&P 500 by 12.679%.

Intuitive Surgical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stryker Corp. offers a yield of 0.91% to investors and pays a quarterly dividend of $0.88 per share. Intuitive Surgical, Inc. pays -- of its earnings as a dividend. Stryker Corp. pays out 40.48% of its earnings as a dividend. Stryker Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Intuitive Surgical, Inc. quarterly revenues are $2.9B, which are smaller than Stryker Corp. quarterly revenues of $7.2B. Intuitive Surgical, Inc.'s net income of $799.5M is lower than Stryker Corp.'s net income of $849M. Notably, Intuitive Surgical, Inc.'s price-to-earnings ratio is 63.42x while Stryker Corp.'s PE ratio is 44.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical, Inc. is 18.00x versus 5.73x for Stryker Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Zimmer Biomet Holdings, Inc. has a net margin of 27.89% compared to Intuitive Surgical, Inc.'s net margin of 6.15%. Intuitive Surgical, Inc.'s return on equity of 16.59% beat Zimmer Biomet Holdings, Inc.'s return on equity of 5.61%.

Intuitive Surgical, Inc. has a consensus price target of $611.82, signalling upside risk potential of 22.48%. On the other hand Zimmer Biomet Holdings, Inc. has an analysts' consensus of $102.65 which suggests that it could grow by 3.43%. Given that Intuitive Surgical, Inc. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe Intuitive Surgical, Inc. is more attractive than Zimmer Biomet Holdings, Inc..

Intuitive Surgical, Inc. has a beta of 1.653, which suggesting that the stock is 65.303% more volatile than S&P 500. In comparison Zimmer Biomet Holdings, Inc. has a beta of 0.619, suggesting its less volatile than the S&P 500 by 38.12%.

Intuitive Surgical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zimmer Biomet Holdings, Inc. offers a yield of 0.97% to investors and pays a quarterly dividend of $0.24 per share. Intuitive Surgical, Inc. pays -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc. pays out 27.04% of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Intuitive Surgical, Inc. quarterly revenues are $2.9B, which are larger than Zimmer Biomet Holdings, Inc. quarterly revenues of $2.2B. Intuitive Surgical, Inc.'s net income of $799.5M is higher than Zimmer Biomet Holdings, Inc.'s net income of $137.9M. Notably, Intuitive Surgical, Inc.'s price-to-earnings ratio is 63.42x while Zimmer Biomet Holdings, Inc.'s PE ratio is 28.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical, Inc. is 18.00x versus 2.40x for Zimmer Biomet Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.